Treatment of CO VID-19 during esophageal cancer surgery:A case report
There is still a lack of experience in the perioperative strategy for esophageal cancer patients in China during the epidemic of CO VID-19.In December 2022,a 59-year-old male patient with esophageal cancer was admitted to our department.He received 2 cycles of neoadjuvant therapy before surgery,and developed CO VID-19 perioperatively.After treatment,the infection symptoms of the patient were improved,and the postoperative recovery was satisfactory.
NETL
NSTL
万方数据
